Beyond the Abstract - An update on the changing indications for androgen deprivation therapy for prostate cancer, by Dan Arnett, Megan Griffiths, Mike Glode, and Shandra Wilson

Published on 16 July 2012
  • Print

BERKELEY, CA (UroToday.com) - Prostate cancer is the most common non-cutaneous cancer among men in the United States and the second most common cause of cancer death.[2]To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.

Tags:
 Androgen Deprivation therapy
 Beyond the Abstract
 Prostate Cancer